Biotechnology News

December 6, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, across all cancer types, surveyed U.S. oncologists estimate that 69 percent of...

December 6, 2012

CINCINNATI--(BUSINESS WIRE)--Ken Phelps, one of the nation’s leading experts in the 505(b)(2) development pathway, will be a keynote speaker at the EPPIC Annual Conference in San Francisco, January 6.

December 6, 2012

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced it is initiating development of its lead cancer drug...

December 6, 2012

TORONTO--(BUSINESS WIRE)--First U.S. Patient Implanted in Functional Neuromodulation Study of Deep Brain Stimulation for Alzheimer's.

December 6, 2012

MALVERN, Pa.--(BUSINESS WIRE)--TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced that its Smac mimetic birinapant was presented during an oral session at...

December 6, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) invites investors and the general public to listen to a live audio webcast of its 2012 Investor Meeting on Tuesday, December 11, 2012 at 12:00 p.m. ET.     What: Teva’s...

December 6, 2012

HARTFORD, Conn. & THE WOODLANDS, Texas--(BUSINESS WIRE)--Aetna and The US Oncology Network announced results of a cancer management program that achieved equivalent health outcomes with 12% lower costs.

December 6, 2012

SAN MARINO, Calif.--(BUSINESS WIRE)--Operationally, we just reached an important milestone in our Phase 1 physician-initiated clinical trial for ovarian cancer combining sorafenib and our MDT compound.

December 6, 2012

NEW YORK--(BUSINESS WIRE)--Veeva Systems has partnered with Medidata Solutions (NASDAQ: MDSO) to offer the life science industry’s first cloud-based end-to-end solution that integrates clinical documentation and trial development. The two...

December 6, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The average number of thought leaders working with large pharmaceutical companies declined in one year by 26%, according to a Cutting Edge Information study.

December 6, 2012

MENLO PARK, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Protagonist Therapeutics, Inc. and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the expansion of their research collaboration. The collaboration, originally announced in...

December 6, 2012

SEATTLE & SAN ANTONIO--(BUSINESS WIRE)--NanoString today announced positive results from the second clinical validation study of its in vitro diagnostic breast cancer assay based on the PAM50 gene expression signature at SABCS 2012.

December 6, 2012

LEXINGTON, Mass. & MUNICH--(BUSINESS WIRE)--MLL Munich Leukemia Laboratory will present data from a myeloid hematological malignancies gene panel study which was generated using RainDance's ThunderStorm™ System coupled with Illumina’s MiSeq...

December 6, 2012

SALT LAKE CITY--(BUSINESS WIRE)--Lipocine Oral Testosterone Replacement Product Cleared by FDA for Phase III Study

December 6, 2012

AMITYVILLE, N.Y.--(BUSINESS WIRE)--Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today reported results for the Company’s fiscal second quarter ended October 31, 2012. Quarterly Results Net sales for the three months ended October 31, 2012 were $57,...

December 6, 2012

DANVERS, Mass.--(BUSINESS WIRE)--Cell Signaling Technology, Inc. (CST) is pleased to announce that NG-XMT™, CST’s patent-pending proteomics discovery platform can derive antigen-specific monoclonal antibodies from human serum.

December 6, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Daniel Junius,...

December 6, 2012

LONDON--(BUSINESS WIRE)--Discounted report “Antibiotic Resistance 2012: The Antibiotics Development Pipeline and Strategies to Combat Antibiotic Resistance” worked out by Biopharm Reports is available at MarketPublishers.com

December 6, 2012

NOTTINGHAM, England--(BUSINESS WIRE)--First results showing immune response in Phase I/II trial of DNA vaccine for melanoma

December 6, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The company’s partner, Good Technology, has launched its Good Vault™ app, which can be used with Precise Biometrics’ Tactivo™ (STO:PREC) Smart Card & Fingerprint Reader for the iPhone®. Good Vault...

December 5, 2012

FLEMINGTON, N.J.--(BUSINESS WIRE)--Arno Therapeutics, Inc. (OTCBB: ARNI), a clinical-stage biopharmaceutical company focused on the development of oncology therapeutics, today announced that researchers have identified a new immunohistochemistry...

December 5, 2012

AUSTIN, Texas--(BUSINESS WIRE)--The Cancer Prevention and Research Institute of Texas (CPRIT) today announced more than $85 million in funding to support 75 new scientific research projects and scientific recruits to support a variety of cancer-...

December 5, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) announced today that it has established 11.59 p.m. (Dublin time) on December 14, 2012 as the record date in connection with its previously announced separation of a substantial portion of...

December 5, 2012

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading spinal implant manufacturer, today announced that Richard Baron, Senior Vice President and Chief Financial Officer, will meet with institutional investors and participate...

December 5, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule announces December 12 presentation at Oppenheimer Healthcare Conference.

December 5, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus to present at Oppenheimer 23rd Annual healthcare conference

December 5, 2012

ELMWOOD PARK, N.J.--(BUSINESS WIRE)--BioReference Laboratories, Inc. announces earnings release date for 4th quarter and year end 2012.

December 5, 2012

SAN ANTONIO--(BUSINESS WIRE)--A study comparing bioTheranostics’ Breast Cancer Index (BCI) to Oncotype Dx & IHC4 for breast cancer prognosis showed that BCI predicts risk of breast cancer recurrence 5-10 years after treatment.

December 5, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Unified, multi-channel strategies optimize pharmaceutical and device companies’ mobile health efforts, finds Cutting Edge Information.

December 5, 2012

BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation co-hosts a new DIA Webinar, "Adult Oncology: Clinical Outcome Assessments (COAs) & Patient-Reported Outcomes (PROs),” Dec. 11, 11am-12:30pm EST

December 5, 2012

WASHINGTON--(BUSINESS WIRE)--2013 BIO CEO & Investor Conference press kit now available.

December 5, 2012

FARMINGTON, Conn.--(BUSINESS WIRE)--DePuy Orthopaedics offers surgeons another option for hip surgery with their Anterior Approach Surgical Technique as described by Dr. Joel Matta.

December 5, 2012

TORONTO--(BUSINESS WIRE)--Claron Technology Inc. announced today it has raised a first round of mezzanine financing from the Business Development Bank of Canada (BDC).

December 5, 2012

PARSIPPANY, N.J.--(BUSINESS WIRE)--Healthcare Research & Analytics (HRA), a leader in data-driven insights in the market research industry, announced today the appointment of Oleh Denysyk, Pharm.D, MBA, as president. Dr. Denysyk assumes this...

December 5, 2012

CARY, N.C.--(BUSINESS WIRE)--ISR's report compares and contrasts European prescribers' experiences with electronic and in-person detail sessions and interactions with pharmaceutical manufacturers.

December 5, 2012

NEW YORK--(BUSINESS WIRE)--‘OneMedForum’ Panel to Address the Major Opportunities in Digital Health at San Francisco Conference

December 5, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) welcomes today’s announcement from the GAVI Alliance that Pfizer’s pneumococcal conjugate vaccine, Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), is now...

December 5, 2012

HYDERABAD, India--(BUSINESS WIRE)--The Association of Eye Banks of Asia (AEBA) presented its inaugural award for “pioneering contributions to eye banking.

December 5, 2012

BEVERLY, Mass.--(BUSINESS WIRE)--BIOBASE has been appointed as an exclusive distributor of ANNOVAR for commercial use.

December 5, 2012

MONTREAL--(BUSINESS WIRE)--First implant of Sorin's PARADYM RF in Canada. The PARADYM RF family of ICD and CRTD devices is fully supported supported by the recently launched SMARTVIEW remote monitoring system.

December 5, 2012

WOBURN, Mass.--(BUSINESS WIRE)--CryoXtract Instruments, a leading provider of automated solutions for preserving and optimizing frozen biological samples, appoints John A. McCarthy, Jr. as Chief Executive Officer to drive growth.

December 5, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch of febuxostat (Takeda’s Uloric, Ipsen/Menarini’s Adenuric, Teijin’s...

December 5, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that by year-end 2015, surveyed rheumatologists in the EU5 (France, Germany, Italy,...

December 5, 2012

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Global Biopharma purchases Instem SEND Software

December 5, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Updated OS data for FASLODEX® (fulvestrant) Injection in patients with hormone receptor-positive advanced breast cancer whose disease progressed or recurred following prior endocrine therapy presented

December 5, 2012

ST. LOUIS--(BUSINESS WIRE)--Plexxikon selects D360 for scientific data access, data mining, and analysis; enables researchers to easily query and analyze biological assay and chemical registration data from a single dashboard.

December 5, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only The management of bleeding associated with the novel oral anticoagulants is one of the topics of interest at this year’s annual meeting of the American Society...